European Organisation for Research and Treatment of Cancer (EORTC)

The European Organisation for Research and Treatment of Cancer (EORTC) is a non-governmental, non-profit organisation, which unites clinical cancer research experts, throughout Europe, to define better treatments for cancer patients to prolong survival and improve quality of life. Spanning from translational to large, prospective, multi-centre, phase III clinical trials that evaluate new therapies and treatment strategies as well as patient quality of life, its activities are coordinated from EORTC Headquarters, a unique international clinical research infrastructure, based in Brussels, Belgium.

As an independent, non-profit cancer research organisation, Their mission is to coordinate and conduct international translational and clinical research to improve the standard of cancer treatment for patients.

Their aim ultimately to increase people’s survival and quality of life by testing new therapeutic strategies based on existing drugs, surgery and radiotherapy. They also help develop new drugs and approaches in partnership with the pharmaceutical industry and in patients’ best interests.

EORTC is uniquely:
• International: EORTC manages clinical research activities across 35 countries.
• Multidisciplinary: Their research spans all aspects of cancer management, from imaging and radiology to surgery and therapeutic innovations, backed by cutting-edge expertise in all fields.
• Multi-tumour: thanks to Their broad-ranging network of oncology experts, no tumour is too rare to tackle. Their research is solution-driven, for all types of cancers, leaving no-one behind.
• Compliant with regulation: in today’s complex regulatory environment, EORTC’s experts ensure Their activities meet the strictest quality and reliability requirements, everywhere They are active.
• Independent: Their research is conducted under conditions of unwavering independence and accountability and all results are made public, to ensure patients and the oncology community benefit from Their learnings.